EP0215876A1 - Blutverflüssigende pharmazeutische präparate - Google Patents

Blutverflüssigende pharmazeutische präparate

Info

Publication number
EP0215876A1
EP0215876A1 EP86901898A EP86901898A EP0215876A1 EP 0215876 A1 EP0215876 A1 EP 0215876A1 EP 86901898 A EP86901898 A EP 86901898A EP 86901898 A EP86901898 A EP 86901898A EP 0215876 A1 EP0215876 A1 EP 0215876A1
Authority
EP
European Patent Office
Prior art keywords
atrox
venom
combination
bothrops
venoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP86901898A
Other languages
English (en)
French (fr)
Inventor
Pascal Berdal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0215876A1 publication Critical patent/EP0215876A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum

Definitions

  • TITLE pharmaceutical preparations which thin the blood:
  • the present innovation consists in combining in the same medicament at least two constituents chosen from a different group from the following groups: anticoagulants and (or) platelet antiaggregants; serum and / or anti-tissue antibodies; venoms and / or toxins; tissue extracts; substances previously known as procoagulant agents.
  • venoms and (or) toxins the venoms of élaps corallinus, naja tripudians, naja nigricollis, vipera aspis, vipéra bitis, vipera daboia, vipera torva, crotalus horridus, lachesis mutus, lachesis alternatus, bothrops atrox atrox, scorpio europeus, scorpio palmatus, prionurus australis, apis mellifica, apium virus, vespa crabo, vespa bombo, latrodectus mactans; as well as extracts (e.g. protein fractions) of venoms and toxins and (or) the corresponding antisera.
  • extracts e.g. protein fractions
  • procoagulant substances thrombin, fibrin, fibrinogen, coagulation factors, phospholipids, platelets, platelet extracts and other coagulation activators.
  • procoagulant substances thrombin, fibrin, fibrinogen, coagulation factors, phospholipids, platelets, platelet extracts and other coagulation activators.
  • thrombin acetylsalicylic acid (dose less than or equal to one gram per day) venom of bothrops lanceolatus
  • Example 2 acetylsalicylic acid venom of bothrops lanceolatus serum and (or) antibodies against blood platelets
  • the presentations of these drugs can be solid or liquid under all Possible pharmaceutical forms prepared according to methods known to those skilled in the art.
  • the active principles can be incorporated into all possible vehicles and excipients used in pharmaceutical compositions. Venoms, sera, antibodies, procoagulant substances will be used at a dilution greater than or equal to the third decimal dilution.

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP86901898A 1985-03-18 1986-03-17 Blutverflüssigende pharmazeutische präparate Withdrawn EP0215876A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8503965 1985-03-18
FR8503965A FR2578745B1 (fr) 1985-03-18 1985-03-18 Preparations pharmaceutiques fluidifiant le sang

Publications (1)

Publication Number Publication Date
EP0215876A1 true EP0215876A1 (de) 1987-04-01

Family

ID=9317296

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86901898A Withdrawn EP0215876A1 (de) 1985-03-18 1986-03-17 Blutverflüssigende pharmazeutische präparate

Country Status (4)

Country Link
EP (1) EP0215876A1 (de)
AU (1) AU5625786A (de)
FR (1) FR2578745B1 (de)
WO (1) WO1986005399A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4140981B2 (ja) * 1994-12-26 2008-08-27 東菱薬品工業株式会社 再狭窄症及び動脈硬化症治療薬
JP3742675B2 (ja) * 1995-06-28 2006-02-08 東菱薬品工業株式会社 虚血−再灌流障害の予防および治療薬
IL123001A (en) * 1998-01-20 1998-12-06 Shulov Inst For Venom Research Analgesic fraction from snake March and pharmacy preparations containing it
AU2005273487B9 (en) * 2004-08-16 2011-08-04 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Method and composition for modulation of Systemic Inflammatory Responses Syndrome (SIRS)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6256M (de) * 1967-01-26 1968-08-19
FR2222083B1 (de) * 1973-03-22 1976-05-14 Fontaine Michel
FR2487201B2 (fr) * 1980-03-24 1985-07-05 Pasteur Institut Preparation lymphocytaires applicables en therapeutique humaine, procede d'obtention et applications

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8605399A1 *

Also Published As

Publication number Publication date
FR2578745A1 (fr) 1986-09-19
AU5625786A (en) 1986-10-13
WO1986005399A1 (fr) 1986-09-25
FR2578745B1 (fr) 1989-05-12

Similar Documents

Publication Publication Date Title
Jimenez-Porras Biochemistry of snake venoms
CA1330299C (en) Composition of anticoagulants
Pérez et al. Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine
AU2008203028B2 (en) Pharmaceutically stable hemostatic compositions
EP0115974B1 (de) Kollagenolytisches Präparat mit hoher Aktivität und dieses enthaltende pharmazeutische Zusammensetzungen
Porges Snake venoms, their biochemistry and mode of action
FR2591485A1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
EP0719791B1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
Marsh et al. The Gaboon viper, Bitis gabonica: hemorrhagic, metabolic, cardiovascular and clinical effects of the venom
FR2555050A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
FR2442241A2 (fr) Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2600895A1 (fr) Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association
AU680929B2 (en) Inhibitor of collagen-stimulated platelet aggregation
Rosenfeld et al. Coagulant, proteolytic, and hemolytic properties of some snake venoms
EP0215876A1 (de) Blutverflüssigende pharmazeutische präparate
WO1996006623A1 (fr) Compositions antithrombotiques et non hemorragiques a base d'heparine, procede pour leur preparation et applications therapeutiques
CA1317878C (en) Method and therapeutic compositions for the treatment of bleeding disorders
Baggai et al. Inhibitory studies of Tamarindus indica seed extract and fractions on hematological activities of Bitis arietans venom
CN101400255B (zh) 用于治疗细菌、病毒、真菌疾病、炎症以及疼痛的组合物
Sani et al. Inhibition of snake venom enzymes and antivenom adjuvant effects of Azadirachta indica A. Juss.(Meliaceae) leaf extracts
JPS62255430A (ja) 哺乳動物の脈管病を治療する方法
Mackay et al. The venom of the boomslang (Dispholidus typus): in vivo and in vitro studies
Peichoto et al. Systemic pathological alterations caused by Philodryas patagoniensis colubrid snake venom in rats
FR2522266A1 (fr) Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu
FR2570278A1 (fr) Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19861219